CN Patent

CN117597108A — 包含氨基甲酸酯化合物的口服水性悬浮液制剂

Assigned to SK Biopharmaceuticals Co Ltd · Expires 2024-02-23 · 2y expired

What this patent protects

本公开涉及一种水性制剂，其包含式1的氨基甲酸酯化合物或其药学上可接受的盐、溶剂化物或水合物作为活性成分、泊洛沙姆和水性载体，其中所述水性制剂是以悬浮液制剂的形式。

USPTO Abstract

本公开涉及一种水性制剂，其包含式1的氨基甲酸酯化合物或其药学上可接受的盐、溶剂化物或水合物作为活性成分、泊洛沙姆和水性载体，其中所述水性制剂是以悬浮液制剂的形式。

Drugs covered by this patent

givinostat-hydrochloride (GIVINOSTAT HYDROCHLORIDE)

Patent Metadata

Patent number: CN117597108A
Jurisdiction: CN
Classification: —
Expires: 2024-02-23
Drug substance claim: No
Drug product claim: No
Assignee: SK Biopharmaceuticals Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.